• LAST PRICE
    3.9120
  • TODAY'S CHANGE (%)
    Trending Up0.0320 (0.8247%)
  • Bid / Lots
    3.8900/ 1
  • Ask / Lots
    3.9400/ 1
  • Open / Previous Close
    3.9099 / 3.8800
  • Day Range
    Low 3.8800
    High 3.9400
  • 52 Week Range
    Low 2.8935
    High 6.0500
  • Volume
    9,439
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3.88
TimeVolumeGNFT
09:32 ET52603.91
09:36 ET15003.9399
09:56 ET1003.89
09:57 ET1003.89
10:21 ET3823.8901
10:30 ET1003.89
10:33 ET1003.89
10:46 ET1003.88
10:48 ET1003.89
10:57 ET1003.939
11:00 ET2003.912
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGNFT
Genfit SA
201.9M
-6.3x
---
United StatesRCEL
AVITA Medical Inc
211.0M
-4.7x
---
United StatesNBTX
Nanobiotix SA
199.8M
-3.6x
---
United StatesMGX
Metagenomi Inc
134.1M
0.0x
---
United StatesMRSN
Mersana Therapeutics Inc
260.6M
-1.9x
---
United StatesCGEN
Compugen Ltd
176.4M
-9.9x
---
As of 2024-06-24

Company Information

Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Contact Information

Headquarters
Parc Eurasante 885 avenue Eugene AvineeLOOS, France 59120
Phone
---
Fax
---

Executives

Chairman of the Board
Jean-Francois Mouney
Independent Vice Chairman of the Board
Xavier Guille Des Buttes
Chief Executive Officer
Pascal Prigent
Chief Financial Officer
Thomas Baetz
Chief Operating Officer
Pascal Caisey

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$201.9M
Revenue (TTM)
$40.8M
Shares Outstanding
49.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.22
EPS
$-0.62
Book Value
$1.46
P/E Ratio
-6.3x
Price/Sales (TTM)
4.9
Price/Cash Flow (TTM)
---
Operating Margin
-69.62%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.